Automated Drug Effectiveness Analysis System

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for determining the relative effectiveness of anti-cancer drugs on live cells are time-consuming and labor-intensive, lacking automation and efficient data processing.

Innovation Solution

A computer system that automates the determination of anti-cancer drug effectiveness by using a processor and memory to manage drug testing parameters, control spectrophotometers, record optical density measurements, calculate activity values, and display correlations between activity values and drug candidates' ability to induce apoptosis in cancer cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If automated computer systems are implemented to manage drug testing parameters and process data, then productivity and speed of analysis are improved, but device complexity increases

Engineering Contradiction:
Improvespeed of drug effectiveness analysisVSAvoidcomplexity of automated system
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The automated system is divided into distinct functional modules: a user interface application for parameter management, a database for storing testing data, a spectrophotometer for optical measurements, and processing software for calculating activity values. This segmentation allows each component to perform its specific function independently, improving overall system productivity while managing complexity through modular design.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The computer system integrates multiple functions into a single automated platform: it manages drug testing parameters, controls the spectrophotometer, records optical density measurements, calculates activity values, and displays results. This multi-functionality eliminates the need for separate manual processes for each task, significantly improving productivity in drug effectiveness analysis.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Loss of time

If manual methods are used for determining drug effectiveness, then device complexity is reduced, but loss of time and productivity decrease

Engineering Contradiction:
Improvetime required for drug testingVSAvoidsimplicity of testing system
Core Design Contradiction:
Loss of timeVSDevice complexity

Solution Approach 1:

The automated system performs data processing and analysis without requiring continuous manual intervention. The computer system automatically records optical density measurements at selected time intervals, calculates activity values from the recorded data, and generates correlation displays between activity values and drug effectiveness. This self-service capability dramatically reduces the time required for drug testing while minimizing the need for complex manual operations.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system replaces manual mechanical processes with automated electronic and optical systems. Instead of manually recording optical density readings and performing calculations, the system uses a spectrophotometer connected to a computer that automatically measures, records, and processes data. This substitution eliminates time-consuming manual operations while managing complexity through software automation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If automated data processing is implemented, then measurement precision and reliability are improved, but device complexity increases

Engineering Contradiction:
Improveaccuracy of activity value calculationVSAvoidcomplexity of data processing system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system incorporates automated feedback loops where optical density measurements are continuously recorded and fed back to the processing software. The computer system automatically calculates activity values based on the recorded data and generates correlation displays that provide feedback on drug effectiveness. This automated feedback mechanism ensures consistent and precise measurements while reducing human error in data interpretation.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system performs preliminary automated processing of optical density data before final analysis. The computer system automatically records measurements at selected time intervals, pre-calculates activity values from the recorded data, and prepares correlation displays before user interpretation. This preliminary automated action ensures measurement precision is maintained throughout the analysis process while managing complexity through systematic data preparation.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system enables quick and accurate analysis of drug effectiveness, reducing the time and effort required for drug testing and providing reliable data for decision-making in oncology.

Implementation Method 1

recording the optical density of the well at a predetermined wavelength at selected time intervals

Methodology Applied
Scientific EffectOptical density measurement: Absorption Spectroscopy

Data Source

PatentUS20250198988A1System and method for automated determination of the relative effectiveness of Anti-cancer drug candidates
Publication Date: 2025.06.19 PIERIAN BIOSCIENCES LLC
  • US20250198988A1 patent drawing
  • US20250198988A1 patent drawing
  • US20250198988A1 patent drawing

AI summary

A computer system is provided for determining the relative effectiveness of anti-cancer drugs. The interface has selectable options, including an option to manage drug testing parameters, and enables user selection of desired drug testing parameters in relation to a virtual well plate associated with a physical well plate of a spectrophotometer. The computer system causes the spectrophotometer to start a drug test, wherein the physical well plate includes at least one test well containing viable cancer cells; and at least one drug candidate in a predetermined concentration; and at least one control well containing the viable cancer cells alone. The system records the optical density of the well at a predetermined wavelength at selected time intervals for a selected duration of time, and stores the optical density and time measurements in the database. An activity value is calculated from the optical density and time measurements, and a correlation is displayed between the activity value and the drug candidate's ability to induce apoptosis in the cancer cells.